Nationwide Recall Issued for Alkaloids Chewable Tablets Due to Undeclared Concentration

Shaman Botanicals, LLC, in conjunction with the U.S. Food and Drug Administration, has initiated a voluntary nationwide recall of a specific lot of Alkaloids Chewable Tablets—White Vein. This action is being taken due to the product containing an undeclared and higher-than-stated concentration of 7-Hydroxymitragynine (7-OH). The company announced this recall on February 13, 2026, with the FDA publishing the announcement on February 17, 2026.

The recalled product, part of the Advanced Alkaloids brand, is identified by Lot number B# AAW.501.3, with all expiration dates affected. The product has been distributed nationwide to wholesalers, retailers, and directly to consumers through online sales. It is available in 2-count bags (UPC Code 810057763724), 20-count bags (UPC Code 810057763830), and 30-count bottles (UPC Code 810057763779). Consumers can identify the specific lot number on the package or the bottom of the bottle.

The reason for this voluntary recall stems from recent testing that revealed the Alkaloids Chewable Tablets—White Vein product contains 7-Hydroxymitragynine (7-OH) at levels exceeding the declared amount of 7.5 mg per tablet. This discrepancy poses a risk to consumers, as ingesting the product could result in a higher dose than intended, potentially leading to adverse health effects. Shaman Botanicals, LLC has reported no adverse events associated with this particular lot of the product.

Consumers who have purchased the affected Alkaloids Chewable Tablets—White Vein are strongly advised to immediately stop using the product and quarantine it. The company is in the process of notifying its distributors and customers via email to arrange for the return of the recalled products. To facilitate this process and to receive a full refund or a replacement product, consumers are instructed to visit the provided URL: https://recall.cbdamericanshaman.com/.

For individuals who have experienced any health issues that they believe may be related to the use of this dietary supplement, it is crucial to consult with a physician or healthcare provider. Additionally, consumers can report any adverse reactions or quality concerns related to this product to the FDA’s MedWatch Adverse Event Reporting program. Reports can be submitted online at http://www.fda.gov/medwatch/report.htm, or by mail or fax using forms available for download at http://www.fda.gov/MedWatch/getforms.htm, or by calling 1-800-332-1088 to request a reporting form.

Shaman Botanicals, LLC has made contact information available for consumers with questions. Vince Sanders, associated with the Quality Department, can be reached at 1501 Iron Street, North Kansas City, MO 64116. Consumers can also call 855-427-7386 or email Quality@CBDAmericanShaman.com. The company is conducting this recall with the full knowledge and cooperation of the U.S. Food and Drug Administration.

Article by Mel Anara, based upon information from U.S. Food and Drug Administration

---